心臓　55/8　2023年8月号

出版社： 日本医学出版
発行日： 2023-08-15
分野： 臨床医学：内科  >  雑誌
ISSN： 05864488
雑誌名：
電子書籍版： 2023-08-15
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

2,200 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,200 円(税込)

購入する

目次

  • Open HEART
    　産官学で目指したunmet needsへの挑戦

    HEART’s Selection
    　心エコーによる最新の循環器疾患診療
    　1．心エコーと話題の心筋症（心アミロイドーシス／心ファブリー病）
    　2．心エコーと最新のSHDカテーテル治療
    　3．Cardiac POCUS・FoCUS：救急医・集中治療医との連携を図る共通言語
    　4．心エコーと最新の心不全診療
    　5．心エコーと最新の腫瘍循環器学(Oncocardiology)診療
    　6．AIを用いた最新の循環器診療―心エコーデータの活用―

    [連載]HEART's　Column
    Authorが語る日本発のクリニカル・エビデンス：論文の解説と発表後の展望
    　Loss of perceived social role, an index of social frailty, is an independent
    　predictor of future adverse events in hospitalized patients with heart failure

    [連載]HEART’s Up To Date
    循環器医が知っておくべき最新のエビデンス

    HEART’s Original
    [臨床研究]
    　入院関連機能障害（Hospitalization-Associated Disability：HAD）を呈した高齢心不全患者の特徴
    [臨床研究]
    　入浴は家庭よりも共同浴場が安全なのか　―入浴中急死リスク評価―
    [症例]
    　ステント留置が奏効した心筋ブリッジの2例
    [Editorial Comment]
    　福田論文に対するEditorial Comment
    [症例]
    　完全房室ブロック発症から6年後に18F-FDG-PETにより心臓サルコイドーシスと診断し,
    　　その治療効果を確認し得た1例
    [Editorial Comment]
    井上論文に対するEditorial Comment

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

【HEART' s Selection】

P.792 掲載の参考文献
1) Benson MD, Buxbaum JN, Eisenberg DS, et al : Amyloid nomenclature 2018 : recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 2018 ; 25 : 215-219
 
2) Kitaoka H, Izumi C, Izumiya Y, et al : JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis. Circ J 2020 ; 84 : 1610-1671
 
3) Kittleson MM, Maurer MS, Ambardekar AV, et al : Cardiac Amyloidosis : Evolving Diagnosis and Management : A Scientific Statement From the American Heart Association. Circulation 2020 ; 142 : e7-e22
 
4) Cuddy SAM, Chetrit M, Jankowski M, et al : Practical Points for Echocardiography in Cardiac Amyloidosis. J Am Soc Echocardiogr 2022 ; 35 : A31-A40
 
5) Garcia-Pavia P, Rapezzi C, Adler Y, et al : Diagnosis and treatment of cardiac amyloidosis : a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2021 ; 42 : 1554-1568
 
6) Ternacle J, Bodez D, Guellich A, et al : Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis. JACC Cardiovasc Imaging 2016 ; 9 : 126-138
 
7) Pagourelias ED, Mirea O, Duchenne J, et al : Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis : A Head-to-Head Comparison of Deformation and Nondeformation Parameters. Circ Cardiovasc Imaging 2017 ; 10 : e005588
PubMed
8) Ruberg FL, Grogan M, Hanna M, et al : Transthyretin Amyloid Cardiomyopathy : JACC State-of-the-Art Review. J Am Coll Cardiol 2019 ; 73 : 2872-2891
 
9) Barros-Gomes S, Williams B, Nhola LF, et al : Prognosis of Light Chain Amyloidosis With Preserved LVEF : Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System. JACC Cardiovasc Imaging 2017 ; 10 : 398-407
 
10) Phelan D, Collier P, Thavendiranathan P, et al : Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 2012 ; 98 : 1442-1448
 
11) Liu D, Hu K, Niemann M, et al : Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy. Circ Cardiovasc Imaging 2013 ; 6 : 1066-1072
 
12) De Gaspari M, Sinigiani G, De Michieli L, et al : Relative apical sparing in cardiac amyloidosis is not always explained by an amyloid gradient. Eur Heart J Cardiovasc Imaging. 2023 May 16 ; jead107
PubMed
13) Usuku H, Yamamoto E, Sueta D, et al : Time-dependent change of relative apical longitudinal strain index in patients with wild-type transthyretin amyloid cardiomyopathy. Int J Cardiol Heart Vasc 2022 ; 43 : 101146
PubMed
14) Bandera F, Martone R, Chacko L, et al : Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis. JACC Cardiovasc Imaging 2022 ; 15 : 17-29
PubMed
15) Singulane CC, Slivnick JA, Addetia K, et al : Prevalence of Right Atrial Impairment and Association with Outcomes in Cardiac Amyloidosis. J Am Soc Echocardiogr 2022 ; 35 : 829-835
 
16) Giancaterino S, Urey MA, Darden D, Hsu JC : Management of Arrhythmias in Cardiac Amyloidosis. JACC Clin Electrophysiol 2020 ; 6 : 351-361
 
17) Tjahjadi C, Fortuni F, Stassen J, et al : Prognostic Implications of Right Ventricular Systolic Dysfunction in Cardiac Amyloidosis. Am J Cardiol 2022 ; 173 : 120-127
 
18) Ternacle J, Krapf L, Mohty D, et al : Aortic Stenosis and Cardiac Amyloidosis : JACC Review Topic of the Week. J Am Coll Cardiol 2019 ; 74 : 2638-2651
 
19) Spada M, Pagliardini S, Yasuda M, et al : High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet 2006 ; 79 : 31-40
 
20) Tower-Rader A, Jaber WA : Multimodality Imaging Assessment of Fabry Disease. Circ Cardiovasc Imaging 2019 ; 12 : e009013
PubMed
21) Kitani Y, Nakagawa N, Sakamoto N, et al : Unexpectedly High Prevalence of Coronary Spastic Angina in Patients With Anderson-Fabry Disease. Circ J 2019 ; 83 : 481-484
 
22) Namdar M, Steffel J, Vidovic M, et al : Electrocardiographic changes in early recognition of Fabry disease. Heart 2011 ; 97 : 485-490
 
23) 日本先天代謝異常学会・編 : ファブリー病診療ガイドライン 2020. 東京 : 診断と治療社 ; 2021
 
24) Hagege A, Reant P, Habib G, et al : Fabry disease in cardiology practice : Literature review and expert point of view. Arch Cardiovasc Dis 2019 ; 112 : 278-287
 
25) Yeung DF, Sirrs S, Tsang MYC, et al : Echocardiographic Assessment of Patients with Fabry Disease. J Am Soc Echocardiogr 2018 ; 31 : 639-649.e2.
 
26) Lenders M, Brand E : FAbry STabilization indEX (FASTEX) : Clinical evaluation of disease progression in Fabry patients. Mol Genet Metab 2020 ; 129 : 142-149
 
27) Perry R, Shah R, Saiedi M, et al : The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease. JACC Cardiovasc Imaging 2019 ; 12 (7 Pt 1) : 1230-1242
 
28) Niemann M, Breunig F, Beer M, et al : The right ventricle in Fabry disease : natural history and impact of enzyme replacement therapy. Heart 2010 ; 96 : 1915-1919
 
29) Kramer J, Niemann M, Liu D, et al : Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease. Eur Heart J 2013 ; 34 : 1587-1596
 
30) Yuasa T, Takenaka T, Higuchi K, et al : Fabry disease. J Echocardiogr 2017 ; 15 : 151-157
 
P.801 掲載の参考文献
1) Mack MJ, Leon MB, Thourani VH, et al : Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patient. N Engl J Med 2019 ; 380 : 1695-1705
 
2) Cribier A, Eltchaninoff H, Koning R, et al : Percutaneous mechanical mitral commissurotomy with a newly designed metallic valvulotome : immediate results of the initial experience in 153 patients. Circulation 1999 ; 99 : 793-799
 
3) Stone GW, Lindenfeld J, Abraham WT, et al : Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med 2018 ; 379 : 2307-2318
 
4) Saver JL, Carroll JD, Thaler DE, et al : Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. N Engl J Med 2017 ; 377 : 1022-1032
PubMed
P.806 掲載の参考文献
1) Robba C, Wong A, Poole D, et al : Basic ultrasound head-to-toe skills for intensivists in the general and neuro intensive care unit population : consensus and expert recommendations of the European Society of Intensive Care Medicine. Intensive Care Med 2021 ; 47 : 1347-1367
 
2) Via G, Hussain A, Wells M, et al : International evidence-based recommendations for focused cardiac ultrasound. J Am Soc Echocardiogr 2014 ; 27 : 683.e1-683.e33
 
3) Levitov A, Frankel HL, Blaivas M, et al : Guidelines for the Appropriate Use of Bedside General and Cardiac Ultrasonography in the Evaluation of Critically Ill Patients-Part II : Cardiac Ultrasonography. Crit Care Med 2016 ; 44 : 1206-1227
 
4) 一般社団法人日本集中治療医学会・編 : 集中治療超音波画像診断テキスト. 東京 : 中外医学社 ; 2023. p.24-35
 
5) Jones AE, Tayal VS, Sullivan DM, Kline JA : Randomized, controlled trial of immediate versus delayed goal-directed ultrasound to identify the cause of nontraumatic hypotension in emergency department patients. Crit Care Med 2004 ; 32 : 1703-1708
 
6) Perera P, Mailhot T, Riley D, Mandavia D : The RUSH exam : Rapid Ultrasound in SHock in the evaluation of the critically lll. Emerg Med Clin North Am 2010 ; 28 : 29-56
 
7) Keikha M, Salehi-Marzijarani M, Soldoozi Nejat R, et al : Diagnostic Accuracy of Rapid Ultrasound in Shock (RUSH) Exam ; A Systematic Review and Meta-analysis. Bull Emerg Trauma 2018 ; 6 : 271-278
 
8) Narang A, Bae R, Hong H, et al : Utility of a Deep-Learning Algorithm to Guide Novices to Acquire Echocardiograms for Limited Diagnostic Use. JAMA Cardiol 2021 ; 6 : 624-632
 
P.812 掲載の参考文献
1) 日本循環器学会/日本心不全学会 : 急性・慢性心不全診療ガイドライン (2017年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2017/06/JCS2017_tsutsui_h.pdf (cited 2023 Jun 15)
 
2) Takenaka T, Teraguchi H, Yoshida A, et al : Terminal stage cardiac findings in patients with cardiac Fabry disease : An electrocardiographic, echocardiographic, and autopsy study. J Cardiol 2008 ; 51 : 50-59
 
3) Yeung DF, Sirrs S, Tsang MYC, et al : Echocardiographic assessment of patients with Fabry disease. J Am Soc Echocardiogr 2018 ; 31 : 639-649.e2
 
4) Perry R, Selvanayagam JB : Echocardiography in infiltrative cardiomyopathy. Heart Lung Circ 2019 ; 28 : 1365-1375
 
5) Phelan D, Collier P, Thavendiranathan P, et al : Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 2012 ; 98 : 1442-1448
 
6) 日本循環器学会/日本心不全学会 : 2021年JCS/JHFSガイドライン フォーカスアップデート版 急性・慢性心不全診療. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Tsutsui.pdf (cited 2023 Jun 15)
 
7) Armstrong PW, Pieske B, Anstrom KJ, et al : Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med 2020 ; 382 : 1883-1893
 
8) Anker SD, Butler J, Filippatos G, et al : Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 2021 ; 385 : 1451-1461
 
9) Nagueh SF, Smiseth OA, Appleton CP, et al : Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2016 ; 29 : 277-314
 
10) Aimo A, Gaggin HK, Barison A, et al : Imaging, biomarker, and clinical predictors of cardiac remodeling in heart failure with reduced ejection fraction. JACC Heart Fail 2019 ; 7 : 782-794
 
11) Merlo M, Pyxaras SA, Pinamonti B, et al : Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol 2011 ; 57 : 1468-1476
 
12) Tobita T, Nomura S, Fujita T, et al : Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling. Sci Rep 2018 ; 8 : 1998
PubMed
13) Stone GW, Abraham WT, Lindenfeld J, et al : Five-year follow-up after transcatheter repair of secondary mitral regurgitation. N Engl J Med 2023 ; 388 : 2037-2048
 
14) Shah SJ, Borlaug BA, Chung ES, et al : Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II) : a randomised, multicentre, blinded, sham-controlled trial. Lancet 2022 ; 399 : 1130-1140
 
15) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会 : 2021年改訂版 重症心不全に対する植込型補助人工心臓治療ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Ono_Yamaguchi.pdf (cited 2023 Jun 18)
 
P.817 掲載の参考文献
1) Lyon AR, Lopez-Fernandez T, Couch LS, et al : 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J Cardiovasc Imaging 2022 ; 23 : e333-e465
 
2) Oikonomou EK, Kokkinidis DG, Kampaktsis PN, et al : Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity : A Systematic Review and Meta-analysis. JAMA Cardiol 2019 ; 4 : 1007-1018
 
3) Awadalla M, Mahmood SS, Groarke JD, et al : Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis. J Am Coll Cardiol 2020 ; 75 : 467-478
 
P.821 掲載の参考文献
1) Attia ZI, Kapa S, Lopez-Jimenez F, et al : Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram. Nat Med 2019 ; 25 : 70-74
 
2) Goto S, Kimura M, Katsumata Y, et al : Artificial intelligence to predict needs for urgent revascularization from 12-leads electrocardiography in emergency patients. PLoS One 2019 ; 14 : e0210103
PubMed
3) Goto S, Goto S, Pieper KS, et al ; Investigators ftG-A : New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists : GARFIELD-AF. Eur Heart J Cardiovasc Pharmacother 2020 ; 6 : 301-309
 
4) Miura K, Goto S, Katsumata Y, et al : Feasibility of the deep learning method for estimating the ventilatory threshold with electrocardiography data. NPJ Digit Med 2020 ; 3 : 141
PubMed
5) Gearhart A, Goto S, Powell AJ, Deo RC : Abstract 10614 : An Automated View Identification Model for Pediatric Echocardiography Using Artificial Intelligence. Circulation 2021 ; 144 : A10614
 
6) Zhang J, Gajjala S, Agrawal P, et al : Fully Automated Echocardiogram Interpretation in Clinical Practice. Circulation 2018 ; 138 : 1623-1635
 
7) Goto S, Goto S : Application of Neural Networks to 12-Lead Electrocardiography -Current Status, Future Directions-. Circ Rep 2019 ; 1 : 481-486
 
8) Goto S, Mahara K, Beussink-Nelson L, et al : Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms, echocardiograms. Nat Commun 2021 ; 12 : 2726
PubMed
9) Goto S, Solanki D, John JE, et al : Multinational Federated Learning Approach to Train ECG, Echocardiogram Models for Hypertrophic Cardiomyopathy Detection. Circulation 2022 ; 146 : 755-769
 
10) Hollopeter G, Jantzen HM, Vincent D, et al : Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001 ; 409 : 202-207
 

【連載】

P.825 掲載の参考文献
1) Watanabe A, Katano S, Yano T, Nagaoka R, Numazawa R, Honma S, Yamano K, Fujisawa Y, Ohori K, Kouzu H, Ishigo T, Katayose M, Hashimoto A, Furuhashi M : Loss of perceived social role, an index of social frailty, is an independent predictor of future adverse events in hospitalized patients with heart failure. Front Cardiovasc Med 2022 ; 9 : 1051570
PubMed
2) Jujo K, Kagiyama N, Saito K, et al : Impact of Social Frailty in Hospitalized Elderly Patients With Heart Failure : A FRAGILE-HF Registry Subanalysis. J Am Heart Assoc 2021 ; 10 : e019954
PubMed
3) Powell-Wiley TM, Baumer Y, Baah FO, et al : Social Determinants of Cardiovascular Disease. Circ Res 2022 ; 130 : 782-799
 

【HEART' s Original】

P.834 掲載の参考文献
1) 公益財団法人 長寿科学振興財団 : 日本の超高齢社会の特徴. https://www.tyojyu.or.jp/net/kenkou-tyoju/tyojyu-shakai/nihon.html (cited 2022 Sep 10)
 
2) 公益財団法人 日本心臓財団 : 超高齢社会で急増する心不全. https://www.jhf.or.jp/check/heart_failure/01/ (cited 2022 Sep 10)
 
3) Shimokawa H, Miura M, Nochioka K, Sakata Y : Heart failure as a general pandemic in Asia. Eur J Heart Fail 2015 ; 17 : 884-892
 
4) 松浦佑哉, 黒崎智之, 井原伸弥, ほか : 心臓リハビリテーションを実施した高齢心不全患者の退院を遅延させる要因の検討. 松江市立医誌 2018 ; 22 : 40-45
 
5) 日本脳卒中学会/日本循環器学会 : 脳卒中と循環器病克服5カ年計画 ストップCVD (脳心血管病) 健康長寿を達成するために. https://www.pref.tottori.lg.jp/secure/1248320/five_year_plan.pdf (cited 2022 Sep 10)
 
6) 日本循環器学会/日本心不全学会 : 急性・慢性心不全診療ガイドライン (2017年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2017/06/JCS2017_tsutsui_h.pdf (cited 2022 Sep 10)
 
7) Covinsky KE, Pierluissi E, Johnston CB : Hospitalization-Associated-Disability "She Was Probably Able to Ambulate, but I'm Not Sure". JAMA 2011 ; 306 : 1782-1793
 
8) Loyd C, Markland AD, Zhang Y, et al : Prevalence of Hospital-Associated Disability in Older Adults : A Meta-analysis. J Am Med Dir Assoc 2020 ; 21 : 455-461
 
9) 高橋佑太, 秋保光利, 今井亮介, ほか : 間質性肺疾患患者における入院関連能力低下の発生率と臨床的アウトカムへの影響-2施設共同前向き観察研究-. 理学療法学 2021 ; 48 : 590-597
 
10) Takara Y, Saitoh M, Morisawa T, et al : Clinical Characteristics of Elderly Heart Failure Patients With Hospital-Acquired Disability : A Preliminary, Single-Center, Observational Study. Cardiol Res 2021 ; 12 : 293-301
 
11) 日本循環器学会/日本心臓リハビリテーション学会 : 2021年改訂版 心血管疾患におけるリハビリテーションに関するガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Makita.pdf (cited 2022 Sep 10)
 
12) Bouillanne O, Morineau G, Dupont C, et al : Geriatric Nutritional Risk Index : a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr 2005 ; 82 : 777-783
 
13) Fujiwara Y, Suzuki H, Yasunaga M, et al : Brief screening tool for mild cognitive impairment in older Japanese : validation of the Japanese version of the Montreal Cognitive Assessment. Geriatr Gerontol Int 2010 ; 10 : 225-232
 
14) Kanda Y : Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplanta 2013 ; 48 : 452-458
 
15) Balu S : Differences in psychometric properties, cut-off scores, and outcomes between the Barthel Index and Modified Rankin Scale in pharmacotherapy-based stroke trials : systematic literature review. Curr Med Res Opin 2009 ; 25 : 1329-1341
 
16) Saitoh M, Takahashi Y, Okamura D, et al : Prognostic impact of hospital-acquired disability in elderly patients with heart failure. ESC Heart Fail 2021 ; 8 : 1767-1774
 
17) 篠原智行, 土田奈生子, 山根達也, ほか : 入院中の日常生活活動能力低下の原因分析-ADL維持向上等体制加算算定病棟におけるコホート研究-. 理学療法科学 2019 ; 34 : 645-651
 
18) 佐藤知香, 梅本安則, 田島文博 : 安静臥床が及ぼす全身への影響と離床や運動負荷の効果について. Jpn J Rehabil Med 2019 ; 56 : 842-847
 
19) 橋立博幸, 島田裕之, 潮見泰藏, 笹本憲男 : 高齢者における筋力増強運動を含む機能的トレーニングが生活機能に及ぼす影響. 理学療法学 2012 ; 39 : 159-166
 
20) 吉田博之, 皿澤克彦, 榊原圭一, ほか : 慢性心不全急性増悪に対するクリニカルパス導入効果の検証. 日本クリニカルパス学会誌 2013 ; 15 : 93-96
 
21) 小澤哲也, 齊藤正和, 堀健太郎, ほか : 入院期高齢心不全患者に対する歩行能力を維持するための離床開始時期の検討. 理学療法学 2015 ; 42 : 26-34
 
22) Ide T, Kaku H, Matsushima S, et al : Clinical Characteristics and Outcomes of Hospitalized Patients With Heart Failure From the Large-Scale Japanese Registry Of Acute Decompensated Heart Failure (JROADHF). Circ J 2021 ; 85 : 1438-1450
 
P.842 掲載の参考文献
1) 畔柳三省, 熊谷哲雄, 松尾義裕, ほか : 東京都23区内における入浴中の死亡. 心臓 2000 ; 32 (Suppl 5) : 38-47
 
2) 厚生労働科学研究費補助金 循環器疾患・糖尿病等生活習慣病対策総合研究事業 : 入浴関連事故の実態把握及び予防対策に関する研究 (研究代表者 : 堀進悟). 2014.
 
3) Suzuki M, Shimbo T, Ikaga T, Hori S : Incidence and Characteristics of Bath-related Accidents. Intern Med 2019 ; 58 : 53-62
 
4) 黒木尚長 : 入浴関連事故の実態把握および病態, 予防に関する研究. 科研研究助成事業研究成果報告書 (平成30年6月21日). https://kaken.nii.ac.jp/ja/file/KAKENHI-PROJECT-15K08882/15K08882seika.pdf (cited 2019 Nov)
 
5) 前田敏明, 前田貴子 : 問診による浴槽浴事故の調査研究-従来調査法との比較-. 心臓 2022 ; 54 : 777-784
 
6) 前田貴子, 前田敏明 : 浴槽浴中急死の一主要機序. 心臓 2022 ; 54 : 1264-1271
 
7) Suzuki M, Ikaga T, Hori S : Relationship between Bath-related Deaths and Low Air Temperature. Intern Med 2017 ; 56 : 3173-3177
 
8) e-Stat政府統計の総合窓口 : 交通事故以外の不慮の事故 (W00-X59) による死亡数, 年齢 (特定階級) ・外因 (三桁基本分類) ・発生場所別. https://www.e-stat.go.jp/dbview?sid=0003411706 (cited 2021 Jun 30)
 
9) 高橋伸彦, 斉藤昌彦, 佐藤正孝, 亀川富士雄 : 入浴中の突然死について-温泉地における旅行者地域住民の比較. 日温気物理医会誌 1999 ; 62 : 87-94
 
10) Suzuki M, Shimbo T, Ikaga T, Hori S : Sudden death phenomenon while bathing in Japan-mortality data-. Circ J 2017 ; 81 : 1144-1149
 
11) Nagasawa Y, Komori S, Sato M, et al : Effects of hot bath immersion on autonomic activity and hemodynamics : comparison of the elderly patient and the healthy young. Jpn Circ J 2001 ; 65 : 587-592
 
P.848 掲載の参考文献
1) Sternheim D, Power DA, Samtani R, et al : Myocardial Bridging ; Diagnosis, Functional Assessment, and Management : JACC State-of-the-Art Review. J Am Coll Cardiol 2021 ; 78 : 2196-2212
 
2) Ding H, Zhang Y, Liu Y, et al : Simulated coronary arterial hemodynamics of myocardial bridging. Rev Cardiovasc Med 2019 ; 20 : 273-280
 
3) Ishikawa Y, Akasaka Y, Akishima-Fukasawa Y, et al : Histopathologic profiles of coronary atherosclerosis by myocardial bridge underlying myocardial infarction. Atherosclerosis 2013 ; 226 : 118-123
 
4) Montone RA, Gurgoglione FL, Del Buono MG, et al : Interplay Between Myocardial Bridging and Coronary Spasm in Patients With Myocardial Ischemia and Non-Obstructive Coronary Arteries : Pathogenic and Prognostic Implications. J Am Heart Assoc 2021 ; 10 : e020535
PubMed
5) 酒井隆, 佐伯公子, 小澤秀樹, ほか : 頻回の心室頻拍を伴う急性心筋梗塞を生じた高度myocardial bridgeの1例. 心臓 1996 ; 28 : 203-209
 
6) 佐久間理吏, 上白土洋俊, 井上晃男, ほか : 心筋梗塞発症に心筋ブリッジと冠攣縮が関与したと考えられた1例. 心臓 2000 ; 32 : 95-99
 
7) 岡田了三 : [Editorial Comment] 心筋梗塞と心筋ブリッジ. 心臓 2000 ; 32 : 100-101
 
8) Teragawa H, Oshita C, Ueda T : The Myocardial Bridge : Potential Influences on the Coronary Artery Vasculature. Clin Med Insights Cardiol 2019 ; 13 : 1179546819846493
PubMed
9) Cai XQ, Jing J, Wen J, et al : Quantitative flow ratio and intravascular ultrasound guided percutaneous coronary intervention of left anterior descending lesion concomitant with severe coronary myocardial bridge. J Geriatr Cardiol 2019 ; 16 : 905-908
 
10) Pourhoseini S, Bakhtiari M, Babaee A, et al : Increased risk of coronary perforation during percutaneous intervention of myocardial bridge : What histopathology says. J Cardiovasc Thorac Res 2017 ; 9 : 108-112
 
11) Kunamneni PB, Rajdev S, Krishnan P, et al : Outcome of intracoronary stenting after failed maximal medical therapy in patients with symptomatic myocardial bridge. Catheter Cardiovasc Interv 2008 ; 71 : 185-190
 
12) Srinivasan M, Prasad A : Metal fatigue in myocardial bridges : stent fracture limits the efficacy of drug-eluting stents. J Invasive Cardiol 2011 ; 23 : E150-152
 
13) Bangalore S, Toklu B, Patel N, et al : Newer-Generation Ultrathin Stent Durg-Eluting Stent Versus Older Second-Generation Thicker Stent Durg-Eluting Stents for Coronary Artery Disease. Circulation 2018 ; 138 : 2216-2226
 
14) Hu Y, Cong H, Zheng L, Jin D : Flow reserve fraction : the optimal choice in lesion assessing and interventional guiding for patient with unstable angina pectoris and intermediate lesion wrapped with myocardial bridge : a case report. J Cardiothorac Surg 2021 ; 16 : 336
 
P.849 掲載の参考文献
1) Sorajja P, Iskandrian AE, Tarantini G : Myocardial bridging of the coronary arteries. UpToDate Inc ; 2021. https://www.uptodate.com/contents/myocardial-bridging-of-the-coronary-arteries (cited 2023 Jun 30)
 
2) Sternheim D, Power DA, Samtani R, et al : Myocardial Bridging : Diagnosis, Functional Assessment, and Management : JACC State-of-the-Art Review. J Am Coll Cardiol 2021 ; 78 : 2196-2212
 
3) Roberts W, Charles SM, Ang C, et al : Myocardial bridges : A meta-analysis. Clin Anat 2021 ; 34 : 685-709
 
4) Gould KL, Johnson NP : Myocardial Bridges : Lessons in Clinical Coronary Pathophysiology. JACC Cardiovasc Imaging 2015 ; 8 : 705-709
 
P.855 掲載の参考文献
1) 日本循環器学会 : 循環器ガイドラインシリーズ 2016年版 : 心臓サルコイドーシスの診療ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2016_terasaki_h.pdf (cited 2023 Jan 31)
 
2) Yazaki Y, Isobe M, Hiroe M, et al : Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001 ; 88 : 1006-1010
 
3) Iwai K, Tachibana T, Takemura T, et al : Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn 1993 ; 43 : 372-376
 
4) 加藤靖周, 森本紳一郎 : 心臓サルコイドーシスの臨床像に関する検討～データシートを用いた多施設共同研究 : 中間報告. 日サ会誌 2010 ; 30 : 73-76
 
5) Sekhri V, Sanal S, Delorenzo LJ, et al : Cardiac sarcoidosis : a comprehensive review. Arch Med Sci 2011 ; 7 : 546-554
 
6) Kandolin R, Lehtonen J, Graner M, et al : Diagnosing isolated cardiac sarcoidosis. J Intern Med 2011 ; 270 : 461-468
 
7) Yoshida Y, Morimoto S, Hiramitsu S, et al : Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J 1997 ; 134 : 382-386
 
8) Uemura A, Morimoto S, Hiramitsu S, et al : Histologic diagnostic rate of cardiac sarcoidosis : Evaluation of endomyocardial biopsies. Am Heart J 1999 ; 138 : 299-302
 
9) Bargagli E, Prasse A : Sarcoidosis : a review for the internist. Intern Emerg Med 2018 ; 13 : 325-331
 
10) Birnie DH, Sauer WH, Bogun F, et al : HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014 ; 11 : 1305-1323
 
11) 平賀洋明, 岩井和郎, 廣江道昭, ほか : 心臓サルコイドーシス診断の手引き-1992-作成の過程について. 厚生省特定疾患「びまん性肺疾患」調査研究班平成4年度研究報告集 1993 ; 23-24
 
12) 日本サルコイドーシス/肉芽腫性疾患学会, 厚生労働科学 研究費補助金難治性疾患克服研究事業びまん性肺疾患調査研究 班, ほか ; サルコイドーシス診断基準改訂委員会 : サルコイドーシスの診断基準と診断の手引き-2006. 日サ会誌 2007 ; 27 : 89-102
 
13) Terasaki F, Yoshinaga K : New guidelines for diagnosis of cardiac sarcoidosis in Japan. Ann Nucl Cardiol 2017 ; 3 : 42-45
 
14) Okada DR, Bravo PE, Vita T, et al : Isolated cardiac sarcoidosis : A focused review of an underrecognized entity. J Nucl Cardiol 2018 ; 25 : 1136-1146
 
15) Kandolin R, Lehtonen J, Airaksinen J, et al : Cardiac sarcoidosis : epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation 2015 ; 131 : 624-632
 
16) Lynch JP 3rd, Hwang J, Bradfield J, et al : Cardiac involvement in sarcoidosis : evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med 2014 ; 35 : 372-390
 
17) Schatka I, Bengel FM : Advanced imaging of cardiac sarcoidosis. J Nucl Med 2014 ; 55 : 99-106
 
18) Youssef G, Leung E, Mylonas I, et al : The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis : A systematic review and metaanalysis including the Ontario experience. J Nucl Med 2012 ; 53 : 241-248
 
19) Mc Ardle BA, Birnie DH, Klein R, et al : Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by 18F-fluorodeoxyglucose positron emission tomography? Circ Cardiovasc Imaging 2013 ; 6 : 617-626
 
20) Osborne MT, Hulten EA, Singh A, et al : Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol 2014 ; 21 : 166-174
 
21) 日本心臓核医学会 : 心臓サルコイドーシスに対する18F FDG PET検査の手引き 2018年改訂. 心臓核医学 2019 ; 21 : 22-27
 
P.858 掲載の参考文献
1) Terasaki F, Ishizaka N : Deterioration of cardiac function during the progression of cardiac sarcoidosis : diagnosis and treatment. Intern Med 2014 ; 53 : 1595-1605
 
2) Birnie DH, Nery PB, Ha AC, Beanlands RS : Cardiac sarcoidosis. J Am Coll Cardiol 2016 ; 68 : 411-421
 
3) Fujita S, Terasaki F, Miyamura M, et al : A patient with cardiac sarcoidosis in whom an abnormal myocardial uptake of fluorine-18 fluorodeoxyglucose and sustained ventricular tachycardia recurred 3.5 years after discontinuing oral corticosteroid therapy. Intern Med 2020 ; 59 : 2275-2280
 

書評

最近チェックした商品履歴

Loading...